{"title": "Impfung in der Schwangerschaft: kritisch hinterfragt", "author": "Michael Friedl", "url": null, "hostname": null, "description": "Thieme E-Books & E-Journals", "sitename": "Hebamme", "date": "2016-06-26", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Subscribe to RSS\n[https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000024.xml](https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000024.xml)\nDOI: 10.1055/s-0042-106709\nImpfung in der Schwangerschaft: kritisch hinterfragt\n[praxis@michaelfriedl.de](mailto:praxis@michaelfriedl.de)\nPublication History\nPublication Date:\n30 June 2016 (online)\nImpfungen vermitteln ein tr\u00fcgerisches Bild von Sicherheit. Dabei greifen sie gravierend in den gesunden Organismus ein. Und die Liste der mit Impfungen verbundenen Probleme ist lang. Angesichts der Datenlage muss kritisch hinterfragt werden, ob Schwangeren eine Impfung empfohlen werden kann.\n[#](#top)\nEine Schwangerschaft geht mit vielf\u00e4ltigen Ver\u00e4nderungen einher, die z. B. zu einer st\u00e4rkeren Durchblutung und Durchl\u00e4ssigkeit der Gewebe sowie deren besserer Ern\u00e4hrung f\u00fchren. Die glatte Muskulatur wird relaxiert, die Magens\u00e4urebildung gesenkt. Die Hypophyse regt die Nebennieren an, vermehrt Kortison, aber auch andere Hormone auszusch\u00fctten. Diese Ver\u00e4nderungen schaffen optimale Bedingungen f\u00fcr die kindliche Entwicklung.\nDie Auswirkungen auf die immunologischen Zusammenh\u00e4nge sind allerdings zum gr\u00f6\u00dften Teil ungekl\u00e4rt [[\n[45](#BR106709-45)]]. Gleiches gilt f\u00fcr Wirkungen des in Impfstoffen enthaltenen Aluminiums auf\ndie durch die hohe Dynamik der Entwicklung sehr empfindlichen Organe in Embryo und Fetus [[ [6](#OR106709-6)]]. Damit gleicht eine Impfung in der Schwangerschaft einem Blindflug bzw.\neinem Experiment.\nRisiken der Pertussis-Impfung\nIm Blick auf die Mikrozephalief\u00e4lle (vor allem) in Brasilien \u2013 die ersten traten im Oktober 2015 auf \u2013 ist\nzu fragen, welchen Einfluss die Diphterie-Tetanus-Keuchhusten-Impfung, die dort seit Oktober 2014 in der\n27.\u201334. SSW verabreicht wird [[\n[44](#OR106709-44)]], auf den Verlauf der\nZikavirus-Infektionen hat.\nDie ohnehin unbefriedigende Wirksamkeit des Keuchhusten-Impfstoffs von lediglich 53\u201364 % [[\n[1](#JR106709-1)], [ [4](#JR106709-4)]] bzw. f\u00fcr Kinder im Alter von 2 bis 7 Jahren\n41 %, zwischen 8 und 12 Jahren sogar nur 24 % [[ [27](#JR106709-27)]], scheint in den letzten\nJahren noch mehr nachzulassen und f\u00fchrte seit 2012 zu vermehrten Keuchhustenf\u00e4llen. Es verbreiten sich\nUntertypen der Keuchhusten-Bakterien, bei denen der aktuelle azellul\u00e4re Keuchhusten-Impfstoff (Pa) nicht\nwirkt. Sein immunologischer Ansatzpunkt ist das Protein Pertactin, das laut Center of Desease Control (CDC)\n(USA) immer mehr Keuchhusten-Bakterien nicht mehr bilden. Die Forscher werten dies als unmittelbare\nAnpassung an die geimpfte Umgebung [[ [30](#JR106709-30)]]. In jeder Schwangerschaft soll\nerneut geimpft werden \u2013 ungeachtet des Abstands zur letzten [[ [44](#OR106709-44)]].\nAuch langfristig schafft die azellul\u00e4re Keuchhustenimpfung Probleme: Bei Jugendlichen, die von vornherein\nmit Pa grundimmunisiert wurden, liegt die Schutzwirkung vier Jahre nach einer Auffrischung im Schulalter bei\nunter zehn Prozent [[\n[23](#OR106709-23)]]! Es gibt zunehmend Hinweise darauf, dass eine\nKeuchhusteninfektion nach vorangegangener (azellul\u00e4rer) Impfung eine besonders riskante Situation darstellt,\nda es hierbei (anders als bei nicht geimpften Kindern) zu einer deutlich allergieassoziierten\nImmunantwort kommt [[ [16](#JR106709-16)]]. Dies unterst\u00fctzt die Beobachtung, dass f\u00fcr\ndiese Kinder ein deutlich erh\u00f6htes Asthma-Risiko besteht.\nAngesichts dieser Datenlage spricht auch das Robert-Koch-Institut davon, dass, obwohl die klassischen\nKeuchhustenerreger nur beim Menschen vorkommen, \u201eaus heutiger Sicht ... eine Eradikation von Pertussis im\nGegensatz zu anderen impfpr\u00e4ventablen Krankheiten nicht m\u00f6glich\u201c ist. [[\n[33](#OR106709-33)]]\nDie Verschiebung der Erkrankung ins Erwachsenenalter erh\u00f6ht die Komplikationsrate.\nEine niederl\u00e4ndische Studie von 2014 identifizierte vollst\u00e4ndig (keuchhusten-)geimpfte Geschwisterkinder als\ndie wichtigste Ansteckungsquelle f\u00fcr S\u00e4uglinge in den ersten 6 Lebensmonaten [[\n[5](#JR106709-5)]]. Diese Ergebnisse f\u00fchren die Kokonstrategie, die die Pertussisimpfung von\nGeschwisterkindern empfiehlt, um eine Ansteckung zu vermeiden, komplett ad absurdum. Eine Studie aus dem\nJahr 2015 spricht von einem \u201emehrfach nachgewiesenen Versagen\u201c der Kokonstrategie [[ [7](#JR106709-7)], [ [15](#JR106709-15)]] und erkl\u00e4rt dies mit der Zunahme\nkeuchhustengeimpfter, symptomloser Keuchhustenkranker [[ [2](#JR106709-2)]].\nAuch die WHO betont ausdr\u00fccklich, dass sie die Kokonstrategie nicht empfiehlt: \u201eNeo-natal\nimmunization, and vaccination of pregnant women and household contacts (\u201ecocooning\u201c) against pertussis is\nnot recommended by WHO.\u201c[[\n[46](#OR106709-46)]]\nEine (Keuchhusten-)Impfung Schwangerer wird von der WHO nicht empfohlen. Brasilien scheint anders beraten.\nOder ist es Hilflosigkeit? Wenn ein Prinzip nicht funktioniert, wird es zun\u00e4chst intensiviert: Es muss doch\ngelingen! Erst, wenn es unausweichlich ist, wird eine faszinierende Idee (hier: Ausrottung einer Krankheit)\naufgegeben. Die m\u00f6glicherweise unbeherrschbare Wandlungsf\u00e4higkeit der Natur ist sehr schwer anzuerkennen.\nZumal eine Verunsicherung der Bev\u00f6lkerung hinsichtlich der Richtigkeit des Impfprinzips vermieden werden\nsoll [[\n[14](#BR106709-14)]]. Dabei ist eine Ausrottung von Krankheitserregern\nkeineswegs gleichzusetzen mit der Ausrottung von Krankheiten. [#](#top)\nRisiken der Influenza-Impfung\n\u201eWir wissen, dass in den USA der Anteil der Grippetodesf\u00e4lle gleich bleibt, trotz der Tatsache, dass \u00fcber\ndie Jahre eine im\nmer h\u00f6here Zahl von Menschen die Grippe\nimpfung erhalten haben.\u201c[[\n[20](#OR106709-20)]]\n1968 f\u00fchrte die CDC eine randomisierte, doppelt-verblindete Studie durch, um den Effekt der Impfung auf die\nMorbidit\u00e4t und Mortalit\u00e4t zu untersuchen [[\n[38](#JR106709-38)]]. Die Autoren kamen zu dem\nSchluss, \u201edass trotz extensiver Verbreitung des Grippeimpfstoffes ... der Nachweis einer verbesserten\nMorbidit\u00e4t und Mortalit\u00e4t misslungen ist\u201c.\nBei Patienten \u00fcber 65 Jahren finden neueste \u00dcbersichtsarbeiten keinen Einfluss auf die Sterblichkeit dieser\nAltersgruppe [[\n[32](#JR106709-32)]]. Auch die immer wieder behauptete Verminderung von\ngrippeassoziierten Lungenentz\u00fcndungen l\u00e4sst sich bei sauberem methodischen Arbeiten nicht nachweisen [[ [18](#JR106709-18)]]. Eine \u00dcbersichtsarbeit der Cochrane-Collaboration von 2013 findet keinerlei\nNutzen der auch in Deutschland immer wieder propagierten Impfung von medizinischem Personal, das \u00e4ltere\nMenschen betreut [[ [42](#JR106709-42)]]. Um einen Fall von Influenza zu verhindern, m\u00fcssen\nmehr als 70 Menschen geimpft werden.\nMindestens ein Drittel der zu Grunde liegenden Studien wurden von der Impfstoffindustrie gesponsert. Dies\nrelativiert auch die Tatsache, dass keine ernsten unerw\u00fcnschten Arzneimittelwirkungen (UAW) beobachtet\nwurden \u2013 die Studienautoren sprechen selbst von einer \u201ebegrenzten\u201c Datengrundlage f\u00fcr die Beurteilung der\nPh\u00e4nomene [[\n[21](#JR106709-21)]].\n2012/2013 erreichte die Impfung in einer gro\u00dfen Studie eine mittlere Effektivit\u00e4t von gut 20 %, wobei im\nstatistischen \u201eVertrauensbereich\u201c auch negative Werte enthalten sind, es also durchaus m\u00f6glich ist, dass die\nImpfung das Erkrankungsrisiko erh\u00f6hte [[\n[35](#OR106709-35)]].\nDie Sicherheit der Grippeschutzimpfung ist \u2013 gemessen an ihrer breiten Anwendung \u2013 auffallend\nschlecht untersucht. Jefferson beurteilt die meisten der existierenden Studien als methodologisch schlecht.\nSie umfassten meist nur geringe Teilnehmerzahlen und wiesen meist systematische methodische Fehler auf\n(Selektions-Bias) [[\n[19](#JR106709-19)]].\nBei Kindern existiert nur eine einzige, \u00e4ltere Untersuchung mit 35 (!) Teilnehmern. Selbst f\u00fcr Senioren seien insgesamt nur 5 Studien ver\u00f6ffentlicht mit einer Laufzeit von jeweils maximal 7 Tagen und insgesamt 3000 Teilnehmern.\nAngesichts dieser Situation ist umso erschreckender, dass so viele und verschiedenartige UAWs im zeitlichen\nZusammenhang mit der Influenzaimpfung aktenkundig sind: Sie erh\u00f6ht das Risiko, an autoimmunologischer\nGef\u00e4\u00dfentz\u00fcndung (Riesenzellarteriitis) oder rheumatoider Polymyalgie [[\n[40](#JR106709-40)]]\nzu erkranken oder am Churg-Strauss-Syndrom (Asthma und systemische autoimmunologische Gef\u00e4\u00dfentz\u00fcndung)\n[[ [10](#JR106709-10)]].\nDas Gesamtrisiko, nach einer Grippeimpfung an einem sog. Guillain-Barr\u00e9-Syndrom (GBS) zu erkranken, ist um\nmindestens den Faktor 4 [[\n[31](#JR106709-31)]], f\u00fcr eine schwere Verlaufsform des GBS sogar\n8-fach erh\u00f6ht [[ [13](#JR106709-13)]]. Insgesamt ist das GBS eine der h\u00e4ufigsten schweren\nKomplikationen des Grippeimpfstoffes [[ [8](#JR106709-8)], [ [9](#JR106709-9)],\n[ [12](#JR106709-12)], [ [31](#JR106709-31)], [ [41](#JR106709-41)]].\nSogenannte demyelinisierende Erkrankungen, bei denen die Markscheiden der Nervenzellen im Gehirn und\nR\u00fcckenmark zerst\u00f6rt werden (wie die Akute Demyelinisierende Enzephalomyelitis \u2013 ADEM \u2013, eine der Multiplen\nSklerose verwandte, akute Erkrankung) treten immer wieder in engem zeitlichem Zusammenhang zur Grippeimpfung\nauf [[\n[3](#JR106709-3)], [ [11](#JR106709-11)], [ [25](#JR106709-25)], [ [26](#JR106709-26)], [ [36](#JR106709-36)], [ [37](#JR106709-37)]].\nAuch bei Kindern werden immunologische Entz\u00fcndungen des Sehnerven beschrieben \u2013 diese sind h\u00e4ufig ein\nErstsymptom einer Multiplen Sklerose [[\n[24](#JR106709-24)]]; Erblindung durch Sch\u00e4digung des\nSehnerven [[ [22](#JR106709-22)]]; auch die Sch\u00e4digung anderer Hirnnerven [[ [17](#JR106709-17)]]. Neurologische Komplikationen wie Hirnentz\u00fcndung (Enzephalitis) [[ [43](#JR106709-43)]] oder Transverse Myelitis, eine mit L\u00e4hmungen einhergehende Entz\u00fcndung des\nR\u00fcckenmarks [[ [29](#JR106709-29)]].\nDie Liste lie\u00dfe sich fortsetzen (siehe http://www.impf-info.de/die-impfungen/grippe/140-grippe-die-impfung.html, Dr.Steffen Rabe).\n[#](#top)\nDiskussion und Fazit\nKann man bei dieser Datenlage, die sicher nicht alle bestehenden Probleme umfasst, empfehlen, Schwangere zu impfen?\nKarin M\u00f6lling, eine renommierte Virusforscherin, kommt nach Abschluss ihrer beruflichen Karriere zu der Auffassung, dass Viren und Bakterien per se dem Menschen nichts anhaben k\u00f6nnen. Er lebe mit ihnen seit Jahrtausenden in friedlicher Koexistenz, habe sie im wahrsten Sinne verinnerlicht. Nur ein in seinen Grundbed\u00fcrfnissen verletzter und dadurch aus der Balance geratener Organismus biete ihnen Gelegenheit zur Vermehrung.\n\u201eDer Mensch ist ein (...) komplexes \u00d6kosystem (...) in diesem (...) herrscht kein (\u2026) Krieg, (\u2026) sondern\neine Balance (...). Wenn \u00e4u\u00dfere Einfl\u00fcsse die Balance zerst\u00f6ren(,) meistens ist der Mensch selbst der\nVerursacher (...) entstehen Krankheiten. Viren und Bakterien sind (...) Nutznie\u00dfer von (...) Schw\u00e4chen des\nWirts\u201c.[[\n[28](#BR106709-28)]]\nDaher kann man (Entz\u00fcndungs-)Krankheiten auch als Indikatoren f\u00fcr ins Ungleichgewicht geratene geistig-seelisch-k\u00f6rperliche Zusammenh\u00e4nge betrachten. Dann sind Krankheiten nicht der Verlust oder ein Unterliegen im Kampf um die Gesundheit, sondern eine autonome Anstrengung des menschlichen Organismus, zu einer verbesserten Gesundheitslage zu kommen. Der Blick wird auf die pers\u00f6nlich beeinflussbaren und zu gestaltenden Lebensumst\u00e4nde gelenkt.\nDa Impfungen in einen gesunden Menschen eingreifen, gilt es, individuell Vor- und Nachteile aufzusp\u00fcren und sich zu entscheiden. Allgemeine Zwangsma\u00dfnahmen f\u00fchren nicht zur Verantwortung des Einzelnen f\u00fcr seine Gesundheit und die Gemeinschaft.\nDie Haltung des Berufsverbandes der Kinder\u00e4rzte, der von seinen Mitgliedern fordert, die Empfehlungen der\nSTIKO ohne individuelle Abweichungen in Umfang und Zeitpunkt umzusetzen [[\n[14](#BR106709-14)]], f\u00fchrt dazu, dass Fragen nach Nebenwirkungen beantwortet werden mit: \u201eDie gibt es nicht.\u201c\nDabei hat der Bundesgerichtshof anders geurteilt:\n\u201eEntscheidend f\u00fcr die \u00e4rztliche Hinweispflicht ist nicht ein bestimmter Grad der Risikodichte,\ninsbesondere nicht eine bestimmte Statistik. Ma\u00dfgebend ist vielmehr, ob das betreffende Risiko dem Eingriff\nspezifisch anhaftet und es bei seiner Verwirklichung die Lebensf\u00fchrung des Patienten besonders belastet\n(BGHZ 126, 386 ff. (389)). Der Senat h\u00e4lt deshalb daran fest, dass grunds\u00e4tzlich auch u\u0308ber \u00e4u\u00dferst seltene\nRisiken aufzukl\u00e4ren ist.\u201c[[\n[34](#JR106709-34)]]\nDie Impfung mit einem \u201eRecht auf Gesundheit\u201c (gibt es das wirklich?) gleichzusetzen und Eltern abzusprechen,\nihren Kindern dieses \u201eRecht zu verweigern\u201c [[\n[14](#BR106709-14)]], schafft eine\nDiskriminierung und Stigmatisierung von Personen, die ihr pers\u00f6nliches Recht in Anspruch nehmen.\nWenn Eltern berichten, dass selbst bei schwersten Erkrankungen unmittelbar nach einer Impfung behandelnde \u00c4rzte einen Zusammenhang kategorisch ausschlie\u00dfen, wird deutlich, dass ein tr\u00fcgerisches Bild von Sicherheit vorhanden ist. Hier werden gesetzliche und wissenschaftliche Grunds\u00e4tze missachtet. Solche F\u00e4lle m\u00fcssten im Sinne der Arzneimittelsicherheit an das Paul-Ehrlich-Institut (PEI) gemeldet werden. Das kann mittlerweile auch jeder Laie tun.\nJeder Arzt ist prim\u00e4r seinem Patienten verpflichtet. In Zeiten einer alles beherrschenden Wirtschaft, die mit tausenden Lobbyisten in Deutschland Einfluss auf Entscheidungstr\u00e4ger nimmt, sollten Entscheidungen jedes Expertengremiums hinsichtlich der Lauterkeit ihrer Beweggr\u00fcnde und eventueller individueller Verflechtungen hinterfragt werden.\n[#](#top) [#](#top)\n-\nLiteratur\n-\n[1 Ad hoc group for the study of pertussis vaccine. Placebo-controlled trial of two acellular pertussis vaccines in Sweden- protective efficacy and adverse events. Lancet 1988; 1: 955-960]\n-\n[2 Althouse BM, Scarpino SV et al. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Medicin 2015; 13: 146]\n-\n[3 Arai M et al. Acute disseminated encephalomyelitis following influenza vaccination: report of a case with callosal disconnection syndrome. Rinsho Shinkeigaku 2014; 54 (2): 135-9]\n-\n[4 Baxter R et al. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013; 347 f4249]\n-\n[5 Bertilone C et al. Finding the \u201awho\u2018 in whooping cough: vaccinated siblings are important pertussis sources in infants 6 months of age and under. Commun Dis Intell Q Rep 2014; 38 (3): E195-200]\n-\n[6 BGM-Studie summary2014.] [http://www.bmg.gv.at/home/Aluminium_Toxikologie](http://www.bmg.gv.at/home/Aluminium_Toxikologie)\n-\n[7 Castagnini LA, Healy CM et al. Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection. Clin Infect Dis 2012; (1): 78-84]\n-\n[8 Choe YJ et al. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003\u20132010. Vaccine 2011; 29 (44): 7727-32]\n-\n[9 Finch NA et al. Guillain-Barr\u00e9 syndrome in an older man following influenza vaccination. J Am Pharm Assoc (2003) 2014; 54 (2): 188-92]\n-\n[10 Fu MH et al. Churg-Strauss Syndrome Following Vaccination Against 2010 Influenza A (H1N1): A Case Report. Acta Neurol Taiwan 2014; 23 (3): 95-101]\n-\n[11 Fujii K et al. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine. Pediatr Int 2012; 54 (4): 539-41]\n-\n[12 Galeotti F et al. Risk of Guillain-Barr\u00e9 syndrome after 2010\u20132011 influenza vaccination. Eur J Epidemiol 2013; 28 (5): 433-44]\n-\n[13 Geier MR, Geier DA, Zahalsky AC. Influenza vaccination and Guillain Barre syndrome. Clin Immunol 2003; 107: 116-121]\n-\n[14 Hartmann W. Kinder- und Jugendarzt 46. 2015. 4. 15]\n-\n[15 Healy CM et al. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Infect Dis J 2015; 34 (1): 22-26]\n-\n[16 Hendrikx LH et al. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine 2011; 29 (40): 6874-80]\n-\n[17 Ishii K et al. Glossopharyngeal nerve and vagus nerve palsies associated with influenza vaccination. Intern Med 2014; 53 (3): 259-61]\n-\n[18 Jackson ML et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008; 372: 398-405]\n-\n[19 Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006; 333: 912-915]\n-\n[20 Jefferson T. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. Cochrane Database Systematic Review. 23 April 2009]\n-\n[21 Jefferson T et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014; 3] [CD001269](https://www.cochrane.org/CD001269)\n-\n[22 Kawasaki A et al. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J NEUROOPHTHALMOL 1998; 18 (1): 56-9]\n-\n[23 Klein N et al. Kaiser Permanente Study Finds Effectiveness of Routine Tdap Booster Wanes in Adolescents. Pediatrics; 2016]\n-\n[24 Korematsu S et al. Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis. Vaccine 2014; 32 (48): 6345-8]\n-\n[25 Maeda K et al. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccination. Intern Med 2012; 51 (14): 1931-3]\n-\n[26 Machicado JD et al. Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient. Clin Vaccine Immunol 2013; 20 (9): 1485-1486]\n-\n[27 Misegades LK. Estimating the Effectiveness of Acellular Pertussis Vaccines. Clin Infect Dis 2012; 55 (10): 1432-1433 DOI:] [10.1093/cid/cis66](https://doi.org/10.1093/cid/cis66).\n-\n[28 M\u00f6lling K. Supermacht des Lebens. 2015. C.H.Beck; M\u00fcnchen: S14\u20135]\n-\n[29 Nakamura N et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med 2003; 42: 191-4]\n-\n[30 Pawloski LC et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US. Clin Vaccine Immunol 2013; DOI:] [10.1128/CVI.00717-13](https://doi.org/10.1128/CVI.00717-13).\n-\n[31 Prestel J et al. Risk of Guillain\u2013Barr\u00e9 syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf 2014; 23 (11): 1192-1204]\n-\n[32 Rizzo C et al. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 2006; 24 (42\u201343): 6468-75]\n-\n[33 RKI. Pertussis \u2013 Stand 2010.]\n-\n[34 RKI. Hinweise fu\u0308r A\u0308rzte zum Aufkla\u0308rungsbedarf u\u0308ber mo\u0308gliche unerwu\u0308nschte Wirkungen bei Schutzimpfungen/Stand: 2007. Epidemiologisches Bulletin 2007; 22 25: 209]\n-\n[35 Rondy M et al. 2012/13 INFLUENZA VACCINE EFFECTIVENESS AGAINST HOSPITALISED INFLUENZA A(H1N1)PDM09, A(H3N2) AND B: ESTIMATES FROM A EUROPEAN NETWORK OF HOSPITALS. Euro Surveill.; 2015 20 (2). pii=21011]\n-\n[36 Sacheli A et al. Influenza vaccine-induced CNS demyelination in a 50-year-old male. Am J Case Rep 2014; 15: 368-73]\n-\n[37 Shoamanesh A. Acute disseminated encephalomyelitis following influenza vaccination Vaccine. 2011; 29 (46): 8182-5]\n-\n[38 Schoenbaum SC, Mostow SR et al. Studies with Inactivated Influenza Vaccines Purified by Zonal Centrifugation. Bull World Health Organ 1969; 41: 531-535]\n-\n[39 Shimizu M et al. Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab. Clin Vaccine Immunol 2012; 19 (10): 1700-2]\n-\n[40 Soriano A Lupus et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. 2012; 21 (2): 153-7]\n-\n[41 Souayah N et al. Guillain-Barr\u00e9 syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990\u20132009). Neuroepidemiology 2012; 38 (4): 227-32]\n-\n[42 Thomas RE et al. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev 2013; 7] [CD005187](https://www.cochrane.org/CD005187)\n-\n[43 Turkoglu R et al. Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment. Vaccine 2009; 27 (52): 7253-6]\n-\n[44 Vranjac A. Governo Do Estado Secretaria De Estado Da Sau\u0301de, Coordenadoria De Controle De Doen\u00e7as, Centro De Vigil\u00e2ncia Epidemiol\u00f3gica. Informe Te\u0301cnico Vacina Difteria, Te\u0301tano e Coqueluche dTpa. Outubro de 2014]\n-\n[45 Weyerstahl T, Stauber M. Gyn\u00e4kologie und Geburtshilfe. Georg Thieme Verlag KG Stuttgart; 4. Aufl. 2013]\n-\n[46 WHO. Recommendations for routine immunization.. (Abruf 20.02.2016)] [praxis@michaelfriedl.de](mailto:praxis@michaelfriedl.de)\n-\nLiteratur\n-\n[1 Ad hoc group for the study of pertussis vaccine. Placebo-controlled trial of two acellular pertussis vaccines in Sweden- protective efficacy and adverse events. Lancet 1988; 1: 955-960]\n-\n[2 Althouse BM, Scarpino SV et al. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Medicin 2015; 13: 146]\n-\n[3 Arai M et al. Acute disseminated encephalomyelitis following influenza vaccination: report of a case with callosal disconnection syndrome. Rinsho Shinkeigaku 2014; 54 (2): 135-9]\n-\n[4 Baxter R et al. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013; 347 f4249]\n-\n[5 Bertilone C et al. Finding the \u201awho\u2018 in whooping cough: vaccinated siblings are important pertussis sources in infants 6 months of age and under. Commun Dis Intell Q Rep 2014; 38 (3): E195-200]\n-\n[6 BGM-Studie summary2014.] [http://www.bmg.gv.at/home/Aluminium_Toxikologie](http://www.bmg.gv.at/home/Aluminium_Toxikologie)\n-\n[7 Castagnini LA, Healy CM et al. Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection. Clin Infect Dis 2012; (1): 78-84]\n-\n[8 Choe YJ et al. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003\u20132010. Vaccine 2011; 29 (44): 7727-32]\n-\n[9 Finch NA et al. Guillain-Barr\u00e9 syndrome in an older man following influenza vaccination. J Am Pharm Assoc (2003) 2014; 54 (2): 188-92]\n-\n[10 Fu MH et al. Churg-Strauss Syndrome Following Vaccination Against 2010 Influenza A (H1N1): A Case Report. Acta Neurol Taiwan 2014; 23 (3): 95-101]\n-\n[11 Fujii K et al. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine. Pediatr Int 2012; 54 (4): 539-41]\n-\n[12 Galeotti F et al. Risk of Guillain-Barr\u00e9 syndrome after 2010\u20132011 influenza vaccination. Eur J Epidemiol 2013; 28 (5): 433-44]\n-\n[13 Geier MR, Geier DA, Zahalsky AC. Influenza vaccination and Guillain Barre syndrome. Clin Immunol 2003; 107: 116-121]\n-\n[14 Hartmann W. Kinder- und Jugendarzt 46. 2015. 4. 15]\n-\n[15 Healy CM et al. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Infect Dis J 2015; 34 (1): 22-26]\n-\n[16 Hendrikx LH et al. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine 2011; 29 (40): 6874-80]\n-\n[17 Ishii K et al. Glossopharyngeal nerve and vagus nerve palsies associated with influenza vaccination. Intern Med 2014; 53 (3): 259-61]\n-\n[18 Jackson ML et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008; 372: 398-405]\n-\n[19 Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006; 333: 912-915]\n-\n[20 Jefferson T. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. Cochrane Database Systematic Review. 23 April 2009]\n-\n[21 Jefferson T et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014; 3] [CD001269](https://www.cochrane.org/CD001269)\n-\n[22 Kawasaki A et al. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J NEUROOPHTHALMOL 1998; 18 (1): 56-9]\n-\n[23 Klein N et al. Kaiser Permanente Study Finds Effectiveness of Routine Tdap Booster Wanes in Adolescents. Pediatrics; 2016]\n-\n[24 Korematsu S et al. Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis. Vaccine 2014; 32 (48): 6345-8]\n-\n[25 Maeda K et al. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccination. Intern Med 2012; 51 (14): 1931-3]\n-\n[26 Machicado JD et al. Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient. Clin Vaccine Immunol 2013; 20 (9): 1485-1486]\n-\n[27 Misegades LK. Estimating the Effectiveness of Acellular Pertussis Vaccines. Clin Infect Dis 2012; 55 (10): 1432-1433 DOI:] [10.1093/cid/cis66](https://doi.org/10.1093/cid/cis66).\n-\n[28 M\u00f6lling K. Supermacht des Lebens. 2015. C.H.Beck; M\u00fcnchen: S14\u20135]\n-\n[29 Nakamura N et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med 2003; 42: 191-4]\n-\n[30 Pawloski LC et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US. Clin Vaccine Immunol 2013; DOI:] [10.1128/CVI.00717-13](https://doi.org/10.1128/CVI.00717-13).\n-\n[31 Prestel J et al. Risk of Guillain\u2013Barr\u00e9 syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf 2014; 23 (11): 1192-1204]\n-\n[32 Rizzo C et al. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 2006; 24 (42\u201343): 6468-75]\n-\n[33 RKI. Pertussis \u2013 Stand 2010.]\n-\n[34 RKI. Hinweise fu\u0308r A\u0308rzte zum Aufkla\u0308rungsbedarf u\u0308ber mo\u0308gliche unerwu\u0308nschte Wirkungen bei Schutzimpfungen/Stand: 2007. Epidemiologisches Bulletin 2007; 22 25: 209]\n-\n[35 Rondy M et al. 2012/13 INFLUENZA VACCINE EFFECTIVENESS AGAINST HOSPITALISED INFLUENZA A(H1N1)PDM09, A(H3N2) AND B: ESTIMATES FROM A EUROPEAN NETWORK OF HOSPITALS. Euro Surveill.; 2015 20 (2). pii=21011]\n-\n[36 Sacheli A et al. Influenza vaccine-induced CNS demyelination in a 50-year-old male. Am J Case Rep 2014; 15: 368-73]\n-\n[37 Shoamanesh A. Acute disseminated encephalomyelitis following influenza vaccination Vaccine. 2011; 29 (46): 8182-5]\n-\n[38 Schoenbaum SC, Mostow SR et al. Studies with Inactivated Influenza Vaccines Purified by Zonal Centrifugation. Bull World Health Organ 1969; 41: 531-535]\n-\n[39 Shimizu M et al. Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab. Clin Vaccine Immunol 2012; 19 (10): 1700-2]\n-\n[40 Soriano A Lupus et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. 2012; 21 (2): 153-7]\n-\n[41 Souayah N et al. Guillain-Barr\u00e9 syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990\u20132009). Neuroepidemiology 2012; 38 (4): 227-32]\n-\n[42 Thomas RE et al. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev 2013; 7] [CD005187](https://www.cochrane.org/CD005187)\n-\n[43 Turkoglu R et al. Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment. Vaccine 2009; 27 (52): 7253-6]\n-\n[44 Vranjac A. Governo Do Estado Secretaria De Estado Da Sau\u0301de, Coordenadoria De Controle De Doen\u00e7as, Centro De Vigil\u00e2ncia Epidemiol\u00f3gica. Informe Te\u0301cnico Vacina Difteria, Te\u0301tano e Coqueluche dTpa. Outubro de 2014]\n-\n[45 Weyerstahl T, Stauber M. Gyn\u00e4kologie und Geburtshilfe. Georg Thieme Verlag KG Stuttgart; 4. Aufl. 2013]\n-\n[46 WHO. Recommendations for routine immunization.. (Abruf 20.02.2016)]", "language": null, "image": "https://www.thieme-connect.de/products/static/assets/desktop/img/Twitter_Summary_Default.jpg", "pagetype": null, "links": ["/products/ejournals/html/10.1055/s-0042-106709?id=&lang=de", "/products/all/home.html", "/products/ejournals/journals", "/products/ebooks/books", "/products/ebooks/series", "/products/libraryservice", "/products/all/help", "/products/all/contact", "https://www.thieme.de/en/thieme-connect/home-3939.htm", "/products/all/home.html", "#", "#", "#", "#", "#", "javascript:;", "https://www.thieme.de/de/hebamme/profil-5700.htm", "https://www.thieme.de/de/hebamme/diehebamme-herausgeber-11774.htm", "https://www.thieme.de/de/hebamme/mediadaten-diehebamme-5708.htm", "https://www.thieme.de/de/hebamme/mediadaten-diehebamme-5708.htm", "javascript:;", "https://www.thieme.de/de/hebamme/autoren-diehebamme-5704.htm", "javascript:;", "https://www.thieme.de/de/hebamme/abonnement-diehebamme-5707.htm", "https://www.thieme.de/en/thieme-connect/contact-3978.htm", "javascript:;", "https://www.thieme.de/de/hebammenarbeit/forum-hebammenarbeit-1218.htm", "#", "/products/all/alerts", "/products/all/searchprofiles", "/products/all/settings", "/products/user/logoutWithCentralPage", "/products/user/logoutWithCentralPage", "/products/ejournals/buyDocument", "#", "/products/ejournals/issues/10.1055/s-00000024/2023", "/products/ejournals/issues/10.1055/s-00000024/2022", "/products/ejournals/issues/10.1055/s-00000024/2021", "/products/ejournals/issues/10.1055/s-00000024/2020", "/products/ejournals/issues/10.1055/s-00000024/2019", "/products/ejournals/issues/10.1055/s-00000024/2018", "/products/ejournals/issues/10.1055/s-00000024/2017", "/products/ejournals/issues/10.1055/s-00000024/2016", "/products/ejournals/issues/10.1055/s-00000024/2015", "/products/ejournals/issues/10.1055/s-00000024/2014", "/products/ejournals/issues/10.1055/s-00000024/2013", "/products/ejournals/issues/10.1055/s-00000024/2012", "/products/ejournals/issues/10.1055/s-00000024/2011", "/products/ejournals/issues/10.1055/s-00000024/2010", "/products/ejournals/issues/10.1055/s-00000024/2009", "/products/ejournals/issues/10.1055/s-00000024/2008", "/products/ejournals/issues/10.1055/s-00000024/2007", "/products/ejournals/issues/10.1055/s-00000024/2006", "/products/ejournals/issues/10.1055/s-00000024/2005", "/products/ejournals/issues/10.1055/s-00000024/2004", "/products/ejournals/issue/10.1055/s-006-32023", "/products/ejournals/journal/10.1055/s-00000024", "/products/ejournals/sampleIssue/10.1055/s-00000024", "https://www.thieme-connect.de/products/ejournals/journal/10.1055/s-00000020", "https://www.thieme-connect.de/products/ejournals/journal/10.1055/s-00000095", "http://webshop.thieme.de/webshop/category/hippokrates/hebammenarbeit/detail.jsf", "https://www.thieme.de/shop/c/100508", "https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000024.xml", "/products/ejournals/ris/10.1055/s-0042-106709/BIB", "#", "#", "#", "#", "mailto:?subject=Recommendation: Hebamme&body=I would like to recommend this article in Hebamme: %0D%0A %0D%0AImpfung in der Schwangerschaft: kritisch hinterfragt %0D%0A %0D%0AAbstract: http://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0042-106709 %0D%0AFull text HTML: http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0042-106709 %0D%0AFull text PDF: http://www.thieme-connect.de/products/ejournals/pdf/10.1055%2Fs-0042-106709.pdf %0D%0A %0D%0AFree sample issue %0D%0Ahttp://www.thieme-connect.de/products/ejournals/sampleIssue/10.1055/s-00000024", "/products/all/alerts", "/products/ejournals/pdf/10.1055/s-0042-106709.pdf", "/products/ejournals/pdf/10.1055/s-0042-106709.pdf", "#", null, "mailto:praxis@michaelfriedl.de", "www.individuelle-impfentscheidung.de", null, "https://eref.thieme.de/10.1055/s-0042-106709", "/products/ejournals/abstract/10.1055/s-0042-106709", "#htmlfulltext", "#references", "#images", "/products/ejournals/pdf/10.1055/s-0042-106709.pdf", "javascript:;", "#N10861", "#N108D3", "#N1097C", "#N109BE", "#top", null, "#BR106709-45", "#OR106709-6", null, null, "#OR106709-44", "#JR106709-1", "#JR106709-4", "#JR106709-27", "#JR106709-30", "#OR106709-44", "#OR106709-23", "#JR106709-16", "#OR106709-33", "#JR106709-5", "#JR106709-7", "#JR106709-15", "#JR106709-2", "#OR106709-46", "#BR106709-14", "#top", null, null, "#OR106709-20", "#JR106709-38", "#JR106709-32", "#JR106709-18", "#JR106709-42", "#JR106709-21", "#OR106709-35", "#JR106709-19", "#JR106709-40", "#JR106709-10", "#JR106709-31", "#JR106709-13", "#JR106709-8", "#JR106709-9", "#JR106709-12", "#JR106709-31", "#JR106709-41", "#JR106709-3", "#JR106709-11", "#JR106709-25", "#JR106709-26", "#JR106709-36", "#JR106709-37", "#JR106709-24", "#JR106709-22", "#JR106709-17", "#JR106709-43", "#JR106709-29", "#top", null, null, "#BR106709-28", "#BR106709-14", "#JR106709-34", "#BR106709-14", "#top", "#top", null, "https://www.thieme-connect.de/media/hebamme/201603/10-1055-s-0042-106709_i000.jpg", null, null, null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-1/BIB", "https://scholar.google.com/scholar_lookup?title=Placebo-controlled trial of two acellular pertussis vaccines in Sweden- protective efficacy and adverse%0A               events", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-2/BIB", "https://scholar.google.com/scholar_lookup?title=Asymptomatic transmission and the resurgence of Bordetella pertussis", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-3/BIB", "https://doi.org/10.5692/clinicalneurol.54.135", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following influenza vaccination: report of a case with callosal%0A               disconnection syndrome", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-4/BIB", "https://scholar.google.com/scholar_lookup?title=Effectiveness of pertussis vaccines for adolescents and adults: case-control study", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-5/BIB", "https://scholar.google.com/scholar_lookup?title=Finding the %E2%80%9Awho%E2%80%98 in whooping cough: vaccinated siblings are important pertussis sources in infants 6%0A               months of age and under", null, "http://www.bmg.gv.at/home/Aluminium_Toxikologie", "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-6/BIB", "https://scholar.google.com/scholar_lookup?title= BGM-Studie summary2014", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-7/BIB", "https://scholar.google.com/scholar_lookup?title=Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on%0A               Infant Pertussis Infection", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-8/BIB", "https://doi.org/10.1016/j.vaccine.2011.07.129", "https://scholar.google.com/scholar_lookup?title=Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea,%0A               2003%E2%80%932010", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-9/BIB", "https://doi.org/10.1331/JAPhA.2014.13152", "https://scholar.google.com/scholar_lookup?title=Guillain-Barr%C3%A9 syndrome in an older man following influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-10/BIB", "https://scholar.google.com/scholar_lookup?title=Churg-Strauss Syndrome Following Vaccination Against 2010 Influenza A (H1N1): A Case Report", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-11/BIB", "https://doi.org/10.1111/j.1442-200X.2011.03501.x", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-12/BIB", "https://doi.org/10.1007/s10654-013-9797-8", "https://scholar.google.com/scholar_lookup?title=Risk of Guillain-Barr%C3%A9 syndrome after 2010%E2%80%932011 influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-13/BIB", "https://doi.org/10.1016/S1521-6616(03)00046-9", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination and Guillain Barre syndrome", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/BR106709-14/BIB", "https://scholar.google.com/scholar_lookup?title=Kinder- und Jugendarzt 46", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-15/BIB", "https://doi.org/10.1097/INF.0000000000000486", "https://scholar.google.com/scholar_lookup?title=Evaluation of the impact of a pertussis cocooning program on infant pertussis infection", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-16/BIB", "https://doi.org/10.1016/j.vaccine.2011.07.055", "https://scholar.google.com/scholar_lookup?title=Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary%0A               vaccinations in healthy and pertussis infected children", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-17/BIB", "https://doi.org/10.2169/internalmedicine.53.0687", "https://scholar.google.com/scholar_lookup?title=Glossopharyngeal nerve and vagus nerve palsies associated with influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-18/BIB", "https://doi.org/10.1016/S0140-6736(08)61160-5", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a%0A               population-based, nested case-control study", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-19/BIB", "https://doi.org/10.1136/bmj.38995.531701.80", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination: policy versus evidence", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-20/BIB", "https://scholar.google.com/scholar_lookup?title=Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and%0A               meta-analysis", null, "https://www.cochrane.org/CD001269", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-21/BIB", "https://scholar.google.com/scholar_lookup?title=Vaccines for preventing influenza in healthy adults", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-22/BIB", "https://scholar.google.com/scholar_lookup?title=Bilateral anterior ischemic optic neuropathy following influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-23/BIB", "https://scholar.google.com/scholar_lookup?title=Kaiser Permanente Study Finds Effectiveness of Routine Tdap Booster Wanes in Adolescents", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-24/BIB", "https://doi.org/10.1016/j.vaccine.2014.09.053", "https://scholar.google.com/scholar_lookup?title=Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated%0A               optic neuritis", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-25/BIB", "https://doi.org/10.2169/internalmedicine.51.7487", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-26/BIB", "https://doi.org/10.1128/CVI.00307-13", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient", null, "https://doi.org/10.1093/cid/cis66", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-27/BIB", "https://doi.org/10.1093/cid/cis669", "https://scholar.google.com/scholar_lookup?title=Estimating the Effectiveness of Acellular Pertussis Vaccines", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/BR106709-28/BIB", "https://doi.org/10.17104/9783406669705", "https://scholar.google.com/scholar_lookup?title=Supermacht des Lebens", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-29/BIB", "https://doi.org/10.2169/internalmedicine.42.191", "https://scholar.google.com/scholar_lookup?title=Neurologic complications associated with influenza vaccination: two adult cases", null, "https://doi.org/10.1128/CVI.00717-13", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-30/BIB", "https://scholar.google.com/scholar_lookup?title=Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-31/BIB", "https://doi.org/10.1002/pds.3638", "https://scholar.google.com/scholar_lookup?title=Risk of Guillain%E2%80%93Barr%C3%A9 syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-32/BIB", "https://doi.org/10.1016/j.vaccine.2006.06.052", "https://scholar.google.com/scholar_lookup?title=Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination%0A               coverage", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-33/BIB", "https://scholar.google.com/scholar_lookup?title=Pertussis %E2%80%93 Stand 2010", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-34/BIB", "https://scholar.google.com/scholar_lookup?title=Hinweise fu%CC%88r A%CC%88rzte zum Aufkla%CC%88rungsbedarf u%CC%88ber mo%CC%88gliche unerwu%CC%88nschte Wirkungen bei%0A               Schutzimpfungen/Stand: 2007", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-35/BIB", "https://scholar.google.com/scholar_lookup?title=2012/13 INFLUENZA VACCINE EFFECTIVENESS AGAINST HOSPITALISED INFLUENZA A(H1N1)PDM09, A(H3N2) AND B:%0A               ESTIMATES FROM A EUROPEAN NETWORK OF HOSPITALS", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-36/BIB", "https://doi.org/10.12659/AJCR.891416", "https://scholar.google.com/scholar_lookup?title=Influenza vaccine-induced CNS demyelination in a 50-year-old male", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-37/BIB", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following influenza vaccination Vaccine", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-38/BIB", "https://scholar.google.com/scholar_lookup?title=Studies with Inactivated Influenza Vaccines Purified by Zonal Centrifugation", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-39/BIB", "https://doi.org/10.1128/CVI.00309-12", "https://scholar.google.com/scholar_lookup?title=Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving%0A               tocilizumab", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-40/BIB", "https://scholar.google.com/scholar_lookup?title=Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and%0A               review of the literature", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-41/BIB", "https://doi.org/10.1159/000336113", "https://scholar.google.com/scholar_lookup?title=Guillain-Barr%C3%A9 syndrome after influenza vaccination in the United States, a report from the CDC/FDA%0A               vaccine adverse event reporting system (1990%E2%80%932009)", null, "https://www.cochrane.org/CD005187", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-42/BIB", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term%0A               care institutions", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-43/BIB", "https://doi.org/10.1016/j.vaccine.2009.08.111", "https://scholar.google.com/scholar_lookup?title=Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-44/BIB", "https://scholar.google.com/scholar_lookup?title=Governo Do Estado Secretaria De Estado Da Sau%CC%81de, Coordenadoria De Controle De Doen%C3%A7as, Centro De%0A               Vigil%C3%A2ncia Epidemiol%C3%B3gica. Informe Te%CC%81cnico Vacina Difteria, Te%CC%81tano e Coqueluche dTpa", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/BR106709-45/BIB", "/products/ejournals/abstract/10.1055/b-002-94109", "https://scholar.google.com/scholar_lookup?title=Gyn%C3%A4kologie und Geburtshilfe", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-46/BIB", "https://scholar.google.com/scholar_lookup?title=Recommendations for routine immunization.", null, "mailto:praxis@michaelfriedl.de", "www.individuelle-impfentscheidung.de", null, null, null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-1/BIB", "https://scholar.google.com/scholar_lookup?title=Placebo-controlled trial of two acellular pertussis vaccines in Sweden- protective efficacy and adverse%0A               events", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-2/BIB", "https://scholar.google.com/scholar_lookup?title=Asymptomatic transmission and the resurgence of Bordetella pertussis", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-3/BIB", "https://doi.org/10.5692/clinicalneurol.54.135", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following influenza vaccination: report of a case with callosal%0A               disconnection syndrome", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-4/BIB", "https://scholar.google.com/scholar_lookup?title=Effectiveness of pertussis vaccines for adolescents and adults: case-control study", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-5/BIB", "https://scholar.google.com/scholar_lookup?title=Finding the %E2%80%9Awho%E2%80%98 in whooping cough: vaccinated siblings are important pertussis sources in infants 6%0A               months of age and under", null, "http://www.bmg.gv.at/home/Aluminium_Toxikologie", "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-6/BIB", "https://scholar.google.com/scholar_lookup?title= BGM-Studie summary2014", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-7/BIB", "https://scholar.google.com/scholar_lookup?title=Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on%0A               Infant Pertussis Infection", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-8/BIB", "https://doi.org/10.1016/j.vaccine.2011.07.129", "https://scholar.google.com/scholar_lookup?title=Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea,%0A               2003%E2%80%932010", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-9/BIB", "https://doi.org/10.1331/JAPhA.2014.13152", "https://scholar.google.com/scholar_lookup?title=Guillain-Barr%C3%A9 syndrome in an older man following influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-10/BIB", "https://scholar.google.com/scholar_lookup?title=Churg-Strauss Syndrome Following Vaccination Against 2010 Influenza A (H1N1): A Case Report", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-11/BIB", "https://doi.org/10.1111/j.1442-200X.2011.03501.x", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-12/BIB", "https://doi.org/10.1007/s10654-013-9797-8", "https://scholar.google.com/scholar_lookup?title=Risk of Guillain-Barr%C3%A9 syndrome after 2010%E2%80%932011 influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-13/BIB", "https://doi.org/10.1016/S1521-6616(03)00046-9", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination and Guillain Barre syndrome", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/BR106709-14/BIB", "https://scholar.google.com/scholar_lookup?title=Kinder- und Jugendarzt 46", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-15/BIB", "https://doi.org/10.1097/INF.0000000000000486", "https://scholar.google.com/scholar_lookup?title=Evaluation of the impact of a pertussis cocooning program on infant pertussis infection", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-16/BIB", "https://doi.org/10.1016/j.vaccine.2011.07.055", "https://scholar.google.com/scholar_lookup?title=Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary%0A               vaccinations in healthy and pertussis infected children", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-17/BIB", "https://doi.org/10.2169/internalmedicine.53.0687", "https://scholar.google.com/scholar_lookup?title=Glossopharyngeal nerve and vagus nerve palsies associated with influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-18/BIB", "https://doi.org/10.1016/S0140-6736(08)61160-5", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a%0A               population-based, nested case-control study", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-19/BIB", "https://doi.org/10.1136/bmj.38995.531701.80", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination: policy versus evidence", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-20/BIB", "https://scholar.google.com/scholar_lookup?title=Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and%0A               meta-analysis", null, "https://www.cochrane.org/CD001269", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-21/BIB", "https://scholar.google.com/scholar_lookup?title=Vaccines for preventing influenza in healthy adults", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-22/BIB", "https://scholar.google.com/scholar_lookup?title=Bilateral anterior ischemic optic neuropathy following influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-23/BIB", "https://scholar.google.com/scholar_lookup?title=Kaiser Permanente Study Finds Effectiveness of Routine Tdap Booster Wanes in Adolescents", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-24/BIB", "https://doi.org/10.1016/j.vaccine.2014.09.053", "https://scholar.google.com/scholar_lookup?title=Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated%0A               optic neuritis", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-25/BIB", "https://doi.org/10.2169/internalmedicine.51.7487", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccination", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-26/BIB", "https://doi.org/10.1128/CVI.00307-13", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient", null, "https://doi.org/10.1093/cid/cis66", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-27/BIB", "https://doi.org/10.1093/cid/cis669", "https://scholar.google.com/scholar_lookup?title=Estimating the Effectiveness of Acellular Pertussis Vaccines", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/BR106709-28/BIB", "https://doi.org/10.17104/9783406669705", "https://scholar.google.com/scholar_lookup?title=Supermacht des Lebens", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-29/BIB", "https://doi.org/10.2169/internalmedicine.42.191", "https://scholar.google.com/scholar_lookup?title=Neurologic complications associated with influenza vaccination: two adult cases", null, "https://doi.org/10.1128/CVI.00717-13", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-30/BIB", "https://scholar.google.com/scholar_lookup?title=Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-31/BIB", "https://doi.org/10.1002/pds.3638", "https://scholar.google.com/scholar_lookup?title=Risk of Guillain%E2%80%93Barr%C3%A9 syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-32/BIB", "https://doi.org/10.1016/j.vaccine.2006.06.052", "https://scholar.google.com/scholar_lookup?title=Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination%0A               coverage", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-33/BIB", "https://scholar.google.com/scholar_lookup?title=Pertussis %E2%80%93 Stand 2010", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-34/BIB", "https://scholar.google.com/scholar_lookup?title=Hinweise fu%CC%88r A%CC%88rzte zum Aufkla%CC%88rungsbedarf u%CC%88ber mo%CC%88gliche unerwu%CC%88nschte Wirkungen bei%0A               Schutzimpfungen/Stand: 2007", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-35/BIB", "https://scholar.google.com/scholar_lookup?title=2012/13 INFLUENZA VACCINE EFFECTIVENESS AGAINST HOSPITALISED INFLUENZA A(H1N1)PDM09, A(H3N2) AND B:%0A               ESTIMATES FROM A EUROPEAN NETWORK OF HOSPITALS", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-36/BIB", "https://doi.org/10.12659/AJCR.891416", "https://scholar.google.com/scholar_lookup?title=Influenza vaccine-induced CNS demyelination in a 50-year-old male", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-37/BIB", "https://scholar.google.com/scholar_lookup?title=Acute disseminated encephalomyelitis following influenza vaccination Vaccine", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-38/BIB", "https://scholar.google.com/scholar_lookup?title=Studies with Inactivated Influenza Vaccines Purified by Zonal Centrifugation", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-39/BIB", "https://doi.org/10.1128/CVI.00309-12", "https://scholar.google.com/scholar_lookup?title=Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving%0A               tocilizumab", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-40/BIB", "https://scholar.google.com/scholar_lookup?title=Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and%0A               review of the literature", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-41/BIB", "https://doi.org/10.1159/000336113", "https://scholar.google.com/scholar_lookup?title=Guillain-Barr%C3%A9 syndrome after influenza vaccination in the United States, a report from the CDC/FDA%0A               vaccine adverse event reporting system (1990%E2%80%932009)", null, "https://www.cochrane.org/CD005187", "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-42/BIB", "https://scholar.google.com/scholar_lookup?title=Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term%0A               care institutions", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/JR106709-43/BIB", "https://doi.org/10.1016/j.vaccine.2009.08.111", "https://scholar.google.com/scholar_lookup?title=Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-44/BIB", "https://scholar.google.com/scholar_lookup?title=Governo Do Estado Secretaria De Estado Da Sau%CC%81de, Coordenadoria De Controle De Doen%C3%A7as, Centro De%0A               Vigil%C3%A2ncia Epidemiol%C3%B3gica. Informe Te%CC%81cnico Vacina Difteria, Te%CC%81tano e Coqueluche dTpa", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/BR106709-45/BIB", "/products/ejournals/abstract/10.1055/b-002-94109", "https://scholar.google.com/scholar_lookup?title=Gyn%C3%A4kologie und Geburtshilfe", null, "/products/ejournals/ris/10.1055/s-0042-106709/id/OR106709-46/BIB", "https://scholar.google.com/scholar_lookup?title=Recommendations for routine immunization.", null, "javascript:;", null, "https://www.thieme-connect.de/media/hebamme/201603/10-1055-s-0042-106709_i000.jpg", "#top", "https://www.thieme.de/de/thieme-gruppe/Imprint-Thieme-EN.htm", "https://www.thieme.de/de/thieme-gruppe/privacy-policy-statement-Thieme-EN.htm", "/products/"]}